Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125840561 | 12584056 | 1 | I | 20160705 | 20160722 | 20160722 | EXP | HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44013HU | BOEHRINGER INGELHEIM | 66.00 | YR | F | Y | 0.00000 | 20160722 | MD | HU | HU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125840561 | 12584056 | 1 | PS | MICARDIS PLUS | HYDROCHLOROTHIAZIDETELMISARTAN | 1 | Oral | DOSE PER APPLICATION:40/12.5 MG,DAILY DOSE:40/12.5 MG | 21162 | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125840561 | 12584056 | 1 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125840561 | 12584056 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125840561 | 12584056 | Arrhythmia | |
125840561 | 12584056 | Headache | |
125840561 | 12584056 | Hypokalaemia | |
125840561 | 12584056 | Paronychia | |
125840561 | 12584056 | Vasculitis cerebral | |
125840561 | 12584056 | Visual field defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |